Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HCA Healthcare, Inc.HCA · Entity 2929 | SVP & Controller | February 10, 2026 | February 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HCA Healthcare, Inc.
Report date February 10, 2026 · Filed February 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 44,379 |
Ending reported balance
After 2026-02-11 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-02-10 · Grant · Acquired 3,350 · Balance 49,413 F1: On January 30, 2023, the reporting person was granted 1,675 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Row 2 · 2026-02-10 · Tax withholding · Disposed 1,034 · Balance 48,379 Row 3 · 2026-02-11 · Sale · Disposed 4,000 · Balance 44,379 |
Filing footnotes · ownership attribution and instrument terms
F1: On January 30, 2023, the reporting person was granted 1,675 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2026 Filed Feb 12, 2026 18:55 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 4,000 | $505.00 | $2,020,000.00 |
DisclosureSEC source: 0001193125-26-049224 · ownership.xml · nonDerivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,379 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 18:55 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,034 | $502.05 | $519,119.70 |
DisclosureSEC source: 0001193125-26-049224 · ownership.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 48,379 Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 18:55 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 3,350 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-049224 · ownership.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,413 F1 · kind: On January 30, 2023, the reporting person was granted 1,675 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2023-2025. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2023-2025 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 18:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 10,670 | $0.00 Strike: $139.06 | $0.00 |
DisclosureSEC source: 0001193125-26-043147 · ownership.xml · derivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,670 shares Expires 2029-01-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020. Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 18:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 5,674 | $513.76 | $2,915,074.24 |
DisclosureSEC source: 0001193125-26-043147 · ownership.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,063 Read SEC document |
| February 05, 2026 Filed Feb 9, 2026 18:13 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 10,670 | $139.06 | $1,483,770.20 |
DisclosureSEC source: 0001193125-26-043147 · ownership.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2026 Filed Feb 2, 2026 18:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 2,560 | $0.00 Strike: $482.53 | $0.00 |
DisclosureSEC source: 0001193125-26-034009 · ownership.xml · derivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,560 Underlying: Common Stock · 2,560 shares Expires 2036-01-29 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 19:41 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 227 | $321.92 | $73,075.84 |
DisclosureSEC source: 0000950170-25-022667 · ownership.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,067 Read SEC document |
| February 13, 2025 Filed Feb 18, 2025 19:41 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 845 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-022667 · ownership.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,294 F1 · kind: On January 28, 2022, the reporting person was granted 1,630 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted. Read SEC document |
| January 28, 2025 Filed Jan 30, 2025 18:50 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 3,575 | $0.00 Strike: $328.70 | $0.00 |
DisclosureSEC source: 0000950170-25-011264 · ownership.xml · derivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,575 Underlying: Common Stock · 3,575 shares Expires 2035-01-28 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026. Read SEC document |
| July 29, 2024 Filed Jul 29, 2024 17:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 4,000 | $360.20 | $1,440,782.40 |
DisclosureSEC source: 0000950170-24-087383 · ownership.xml · nonDerivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,449 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.05 to $360.205, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 17:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 9,300 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0000950170-24-087383 · ownership.xml · derivative · entry 4 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,300 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 17:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 5,278 | $352.79 | $1,862,025.62 |
DisclosureSEC source: 0000950170-24-087383 · ownership.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,449 Read SEC document |
| July 25, 2024 Filed Jul 29, 2024 17:25 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 9,300 | $101.16 | $940,788.00 |
DisclosureSEC source: 0000950170-24-087383 · ownership.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,727 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,976 | $308.55 | $609,694.80 |
DisclosureSEC source: 0001209191-24-003757 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,427 Read SEC document |
| February 16, 2024 Filed Feb 21, 2024 19:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 5,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003757 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,403 F1 · kind: On February 3, 2021, the reporting person was granted 2,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 05, 2024 Filed Feb 7, 2024 19:45 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 4,000 | $312.42 | $1,249,680.00 |
DisclosureSEC source: 0001209191-24-002971 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,383 Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 4,402 | $0.00 Strike: $304.90 | $0.00 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · derivative · entry 6 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,402 Underlying: Common Stock · 4,402 shares Expires 2034-01-31 F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 31, 2025. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 9,000 | $0.00 Strike: $101.16 | $0.00 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · derivative · entry 5 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,300 Underlying: Common Stock · 9,000 shares Expires 2028-01-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 2,680 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · derivative · entry 4 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,680 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 6,376 | $304.90 | $1,944,042.40 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · nonDerivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,383 Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 9,000 | $101.16 | $910,440.00 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 18:53 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 2,680 | $81.96 | $219,652.80 |
DisclosureSEC source: 0001209191-24-002734 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,759 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 20:11 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,393 | $262.84 | $628,976.12 |
DisclosureSEC source: 0001209191-23-012011 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,079 Read SEC document |
| February 17, 2023 Filed Feb 22, 2023 20:11 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 6,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-012011 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,472 F1 · kind: On January 29, 2020, the reporting person was granted 3,040 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2020-2022. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2020-2022 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 01, 2023 Filed Feb 1, 2023 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 4,900 | $253.30 | $1,241,170.00 |
DisclosureSEC source: 0001209191-23-006045 · doc4.xml · nonDerivative · entry 4 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,392 Read SEC document |
| January 31, 2023 Filed Feb 1, 2023 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 379 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-006045 · doc4.xml · nonDerivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,292 Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 5,052 | $0.00 Strike: $253.30 | $0.00 |
DisclosureSEC source: 0001209191-23-006045 · doc4.xml · derivative · entry 6 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,052 Underlying: Common Stock · 5,052 shares Expires 2033-01-30 F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 12,000 | $0.00 Strike: $81.96 | $0.00 |
DisclosureSEC source: 0001209191-23-006045 · doc4.xml · derivative · entry 5 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,680 Underlying: Common Stock · 12,000 shares Expires 2027-02-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 6,513 | $253.30 | $1,649,742.90 |
DisclosureSEC source: 0001209191-23-006045 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,671 Read SEC document |
| January 30, 2023 Filed Feb 1, 2023 20:08 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 12,000 | $81.96 | $983,520.00 |
DisclosureSEC source: 0001209191-23-006045 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,184 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:22 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 1,836 | $244.10 | $448,167.60 |
DisclosureSEC source: 0001209191-22-012425 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,184 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:22 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 6,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012425 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,020 F1 · kind: On January 30, 2019, the reporting person was granted 3,100 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| January 28, 2022 Filed Feb 1, 2022 19:39 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantStock Appreciation Right · Derivative | 5,550 | $0.00 Strike: $236.61 | $0.00 |
DisclosureSEC source: 0001209191-22-006090 · doc4.xml · derivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,550 Underlying: Common Stock · 5,550 shares Expires 2032-01-28 F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2023. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 19:02 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 2,100 | $252.94 | $531,174.00 |
DisclosureSEC source: 0001209191-21-063722 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,820 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 5,260 | $0.00 Strike: $79.80 | $0.00 |
DisclosureSEC source: 0001209191-21-062529 · doc4.xml · derivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,260 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on May 4, 2017. Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 3,087 | $250.46 | $773,170.02 |
DisclosureSEC source: 0001209191-21-062529 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,920 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 19:36 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 5,260 | $79.80 | $419,748.00 |
DisclosureSEC source: 0001209191-21-062529 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,007 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 4, 2021 19:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 4,604 | $204.00 | $939,216.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 5 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,747 Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 4,990 | $0.00 Strike: $79.80 | $0.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · derivative · entry 7 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,260 Underlying: Common Stock · 4,990 shares Expires 2026-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on May 4, 2017. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 7,010 | $0.00 Strike: $69.58 | $0.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · derivative · entry 6 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,010 shares Expires 2026-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 7,396 | $201.06 | $1,487,039.76 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 4 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,351 Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 4,990 | $79.80 | $398,202.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,747 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 30, 2021 Filed May 4, 2021 19:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionCommon Stock | 7,010 | $69.58 | $487,755.80 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,757 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 24, 2021 Filed May 4, 2021 19:42 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GiftCommon Stock | 433 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-030118 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,747 Read SEC document |
| February 19, 2021 Filed Feb 22, 2021 20:48 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | SaleCommon Stock | 3,200 | $177.06 | $566,579.52 |
DisclosureSEC source: 0001209191-21-013013 · doc4.xml · nonDerivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,180 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $177.02 to $177.15, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:48 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 2,360 | $174.61 | $412,079.60 |
DisclosureSEC source: 0001209191-21-013013 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,380 Read SEC document |
| February 18, 2021 Filed Feb 22, 2021 20:48 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | GrantCommon Stock | 8,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-013013 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,740 F1 · kind: On January 31, 2018, the reporting person was granted 4,980 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2018-2020. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 80% of target) to two times the units granted (for actual performance of 120% or more of target). Based upon the Company's achievement with respect to cumulative 2018-2020 earnings per share, the number of performance share units that vested equaled 162.88% of the units granted. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 19:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Exercise / conversionStock Appreciation Right · Derivative | 8,000 | $0.00 Strike: $68.96 | $0.00 |
DisclosureSEC source: 0001209191-21-009448 · doc4.xml · derivative · entry 3 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2025-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on February 4, 2016. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 19:15 UTC | HCA Healthcare, Inc. HCA · Entity 2929 | Tax withholdingCommon Stock | 4,308 | $178.94 | $770,873.52 |
DisclosureSEC source: 0001209191-21-009448 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,629 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.